Atlas Trials

MG4101 for Refractory or Relapsed AML

Clinical trial NCT03349502 · COMPLETED

Trial details

NCT number
NCT03349502
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2017-11-01
Primary completion
2020-03-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.